Seaport Therapeutics, Inc. (SPTX)
17.15
-1.00
(-5.51%)
USD |
NASDAQ |
Oct 12, 16:00
17.09
-0.06
(-0.35%)
After-Hours: 20:00
Seaport Therapeutics EPS Diluted (Quarterly) : -1.169 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.169 |
| March 31, 2026 | -0.4746 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.2816 |
| March 31, 2025 | -0.2452 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.268 |
| Bristol Myers Squibb Co. | 1.620 |
| Harmony Biosciences Holdings, Inc. | 1.284 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -62.60M |
| Total Expenses (Quarterly) | 62.60M |
| Enterprise Value | 649.76M |
| Earnings Yield | -12.66% |
| Normalized Earnings Yield | -12.66 |